EWTX — EDGEWISE THERAPEUTICS INC

Ownership history in HAP Trading, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which HAP Trading, LLC reported a position in EDGEWISE THERAPEUTICS INC (EWTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q1)
Avg. % of fund
0.01%
First filed
2024 Q4
Last filed
2025 Q1
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q1 UNCHANGED 60,000 — 0% 0.01% $108.0M $22.00
2025 Q1 ADDED 60,000 +40,000 +200.0% 0.01% $94.5M $22.00
2024 Q4 INITIATED 20,000 — — 0.00% $2.9M $26.70
% of Fund (quarterly)    EWTX price (monthly, adj. close)

Other funds also holding EWTX

As of 2025 Q4 — sorted by position size

Novo Holdings A/S 3Y 7Y 10.31% ORBIMED ADVISORS LLC 3Y 7Y 7.86% Ally Bridge Group (NY) LLC 3Y 6.46% Ally Bridge Group (NY) LLC 3Y 5.04% MPM BioImpact LLC 3Y 4.7% Paradigm Biocapital Advisors LP 3Y 4.14% BRAIDWELL LP 3Y 4.14% Cormorant Asset Management, LP 3Y 7Y 3.77% Siren, L.L.C. 3.35% First Light Asset Management, LLC 3Y 7Y 2.99%
← Back to HAP Trading, LLC Holdings